Prosecution Insights
Last updated: April 19, 2026

Ono Pharmaceutical Co. Ltd.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17925934 AGENT FOR PROTECTING AND/OR REGENERATING NEUROMUSCULAR JUNCTION SOROUSH, ALI 1614 Final Rejection Nov 17, 2022
17995686 METHOD FOR REMOVING COLOR FROM DRUG SUBSTANCE OF PROTEIN PREPARATION KIEFER, DALTON EDWARD 1652 Non-Final OA Oct 06, 2022
17633092 BISPECIFIC PROTEIN DARPOLOR, JOSEPHINE KEBBEH 1642 Final Rejection Feb 04, 2022
16858244 QUINOLINE DERIVATIVE DAVIS, BRIAN J 1614 Non-Final OA Apr 24, 2020

Managing Ono Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month